Camp4 Therapeutics Corp (CAMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -80,403 | -51,791 | -49,291 | -44,192 |
| Depreciation Amortization | 1,639 | 1,696 | 1,678 | 878 |
| Accounts payable and accrued liabilities | -1,028 | 168 | -1,115 | 1,331 |
| Other Working Capital | 13,008 | -1,331 | -1,269 | 1,704 |
| Other Operating Activity | 37,231 | 5,696 | 5,842 | 1,736 |
| Operating Cash Flow | $-29,553 | $-45,562 | $-44,155 | $-38,543 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -243 | -441 | -678 | -4,025 |
| Investing Cash Flow | $-243 | $-441 | $-678 | $-4,025 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | N/A | 706 | N/A |
| Debt Repayment | -208 | -824 | -590 | -93 |
| Common Stock Issued | 61,168 | 76,466 | 185 | 55 |
| Other Financing Activity | 14,930 | -3,980 | 0 | 100,195 |
| Financing Cash Flow | $75,890 | $71,662 | $301 | $100,157 |
| Beginning Cash Position | 65,663 | 40,004 | 84,536 | 26,947 |
| End Cash Position | 111,757 | 65,663 | 40,004 | 84,536 |
| Net Cash Flow | $46,094 | $25,659 | $-44,532 | $57,589 |
| Free Cash Flow | ||||
| Operating Cash Flow | -29,553 | -45,562 | -44,155 | -38,543 |
| Capital Expenditure | -279 | -441 | -678 | -4,025 |
| Free Cash Flow | -29,832 | -46,003 | -44,833 | -42,568 |